SunWay Biotech Co., LTD. (TPEX:1271)

Market Cap	3.48B
Revenue (ttm)	970.18M
Net Income (ttm)	118.57M
Shares Out	60.39M
EPS (ttm)	1.96
PE Ratio	29.39
Forward PE	n/a
Dividend	1.33 (2.33%)
Ex-Dividend Date	Apr 11, 2024

Volume	34,981
Average Volume	57,206
Open	57.20
Previous Close	57.10
Day's Range	57.00 - 58.60
52-Week Range	48.65 - 115.55
Beta	-0.16
RSI	42.42
Earnings Date	Apr 20, 2025

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1271

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.